sacituzumab govitecan
gilead sciences
['bcsm', 'tnbc', 'tropics02']
results on tropics02 trial by . sacituzumab govitican (sg) an antibody drug conjugate that has been approved in tnbc. er+ heavily pretreated pts. showed statistically significant pfs over chemo however greater toxicity. #bcsm #asco22 #er+ 
Metastatic Thriver, Lead Research Advocate and Publications Curator- Lobular Breast Cancer Alliance. https://t.co/Nu1hbUN17g; @LobularBCA. Tweets are my own.